Header Logo

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas. Blood Adv. 2020 09 08; 4(17):4256-4266.

View in: PubMed